From: The humanistic, economic and societal burden of Herpes Zoster in Europe: a critical review
Country | HZ/PHN | HZ (without PHN) | PHN |
---|---|---|---|
Belgium [40] | - | €5,982 (€798-31,689) | - |
(all ages) | |||
France [41] | - | €2,774.28 (50+years) | €3,731.09 (50+years) |
Germany [31] | - | €4,189.74 (50+years) | €4,279.68 (50+years) |
€3,282.64 (all ages) | €4,112.03 (all ages) | ||
Italy [29] | - | €3,188.16 ± €1,614.99 (50+years) | €3,451.38 ± €3,248.43 (50+years) |
€3,366.4 -4,505.6 | €5,019.84 (aged 40–49) | €5,108.04 (aged 50–59) | |
(all ages) | €4,495.68 – 5,139.54 (aged 50–59) | €4,732.56 (aged 60–69) | |
€4,210.92 – 4,782.96 (aged 60–69) | €4,478.04 (70+) | ||
€4,062.24 – 4,556.16 (aged 70+) |